FindTrial
Sign In

Molecular biological mechanism of specific immunotherapy in patients with allergic rhinitis

Molecular biological mechanism of specific immunotherapy in patients with allergic rhinitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014854
Enrollment
Unknown
Registered
2018-02-09
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Case series:Immunity therapy

Sponsors

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients according to symptoms, history and nasal examination, diagnosed as allergic rhinitis; 2. years older than 5 years old; 3. No lower respiratory tract diseases (such as asthma, chronic obstructive pulmonary disease, bronchiectasis, etc.), no infection, no tumor and other systemic diseases (such as cardiovascular and cerebrovascular disease, diabetes, chronic liver and kidney disease, etc.)

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
OBK713;VAS score;Skin prick;—

Countries

China

Contacts

Public ContactLi Chunwei

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University

hi_chunwei@aliyun.com+86 13825116483

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026